Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis
暂无分享,去创建一个
K. Naresh | M. Du | Raida Ahmad | H. Mugalaasi | A. Attygalle | K. Vroobel | R. Dobson | D. Wren | Zi Chen | Y. Morgan | Pui Kwan Chak | Manmit Kaur | Pui Kwan Chak | Kikkeri N Naresh
[1] J. Cerhan,et al. High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL) , 2021, Leukemia.
[2] G. Follows,et al. Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis , 2021, Haematologica.
[3] S. Chiba,et al. Advances in understanding of angioimmunoblastic T-cell lymphoma , 2020, Leukemia.
[4] J. Tardif,et al. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. , 2020, Blood advances.
[5] M. Arcila,et al. Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms. , 2020, Blood advances.
[6] G. Follows,et al. Angioimmunoblastic T‐cell lymphoma contains multiple clonal T‐cell populations derived from a common TET2 mutant progenitor cell , 2019, The Journal of pathology.
[7] B. Falini,et al. High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML. , 2018, The New England journal of medicine.
[8] J. Aster,et al. RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice. , 2018, Blood.
[9] S. Barrans,et al. Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality , 2018, Laboratory Investigation.
[10] A. Tzankov,et al. High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations , 2018, Leukemia.
[11] A. Ferrando,et al. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. , 2018, Cancer cell.
[12] B. Taylor,et al. Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS , 2017, Nature.
[13] R. Küppers,et al. TET2 mutations in B cells of patients affected by angioimmunoblastic T‐cell lymphoma , 2017, The Journal of pathology.
[14] P. Gaulard,et al. The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development , 2016, Proceedings of the National Academy of Sciences.
[15] M. Takei,et al. A Clinicopathologic Study of Lennert Lymphoma and Possible Prognostic Factors: The Importance of Follicular Helper T-cell Markers and the Association With Angioimmunoblastic T-cell Lymphoma , 2016, The American journal of surgical pathology.
[16] T. Molina,et al. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets , 2015, Haematologica.
[17] P. Gaulard,et al. The microenvironment in T-cell lymphomas: emerging themes. , 2014, Seminars in cancer biology.
[18] O. Nureki,et al. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma , 2014, Nature Genetics.
[19] W. Klapper,et al. Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology , 2014, Histopathology.
[20] Mithat Gonen,et al. Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.
[21] P. Opolon,et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.
[22] J. Licht,et al. DNMT3A mutations in acute myeloid leukemia , 2011, Nature Genetics.
[23] B. Nathwani,et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. , 2011, Blood.
[24] Sheng-Tsung Chang,et al. Angioimmunoblastic T-cell lymphoma of cytotoxic T-cell phenotype containing a large B-cell proliferation with an undersized B-cell clonal product. , 2010, Applied immunohistochemistry & molecular morphology : AIMM.
[25] D. Gilliland,et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. , 2009, Blood.
[26] W. Erber,et al. A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology , 2007, British journal of haematology.
[27] P. Gaulard,et al. Histologic Evolution of Angioimmunoblastic T-cell Lymphoma in Consecutive Biopsies: Clinical Correlation and Insights Into Natural History and Disease Progression , 2007, The American journal of surgical pathology.
[28] M. Du,et al. Distinguishing angioimmunoblastic T‐cell lymphoma from peripheral T‐cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics , 2007, Histopathology.